Dr. Vance is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
833 Princeton Ave Sw Ste 105a
Pob Iii
Birmingham, AL 35211Phone+1 205-786-6983Fax+1 844-852-2667
Education & Training
University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
Brookwood Baptist HealthResidency, Internal Medicine, 2000 - 2004
University of Alabama School of MedicineClass of 2000
Certifications & Licensure
AL State Medical License 2002 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer Start of enrollment: 2013 Nov 01
Publications & Presentations
PubMed
- 51 citationsDPYD*2A mutation: the most common mutation associated with DPD deficiencyMuhammad Wasif Saif, Hany Ezzeldin, Katisha T. Vance, Sandra Sellers, Robert B. Diasio
Cancer Chemotherapy and Pharmacology. 2007-07-17
Professional Memberships
- Member
- Member
- Jefferson County Medical SocietyMember
- Medical Association of the State of AlabamaMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
